EXCLUSIVE: Enlivex Raises Over $200 Million To Launch First Public Company Prediction Markets Play

Enlivex Therapeutics Ltd. (NASDAQ:ENLV) on Monday announced a private investment in public equity of 212 million shares at $1.00 per share, representing a premium of 11.5% from the closing price of the stock on November 21, 2025. The company expects gross proceeds of approximately $212 million (funded in a combination of $USD and USDT). Enlivex will use the proceeds from the PIPE to implement the first RAIN prediction markets token treasury strategy, while continuing its focus on the company's core busine ...